Effect of Croscormellose Sodium in Sustained Release Layer of Valsartan in Bilayer Tablet with Clopidogrel as Immediate Drug Release and Valsartan as Sustained Drug Release
The aim of the study was to design and evaluate bilayer tablets of clopidogrel as immediate release and quick relief and valsartan for sustained release and check the effect of croscarmellose sodium (2%) in Carbopol for sustained release action. Bilayer tablets was prepared using direct compression...
Gespeichert in:
Veröffentlicht in: | Journal of drug delivery and therapeutics 2023-12, Vol.13 (12), p.35-50 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 50 |
---|---|
container_issue | 12 |
container_start_page | 35 |
container_title | Journal of drug delivery and therapeutics |
container_volume | 13 |
creator | Fatima, Hajra Mohammed, Shahid Begum, Arshiya |
description | The aim of the study was to design and evaluate bilayer tablets of clopidogrel as immediate release and quick relief and valsartan for sustained release and check the effect of croscarmellose sodium (2%) in Carbopol for sustained release action. Bilayer tablets was prepared using direct compression method. Super disintegrants such as Crospovidone, Croscarmellose sodium were evaluated for immediate release of clopidogrel. Polymers HPMC K4, guar gum, ethyl cellulose and carbopol for controlling release of Valsartan. The compressed bilayer tablets were evaluated for weight variation, thickness, hardness, friability, drug content and in vitro drug release in 0.1N HCl and phosphate buffer pH 6.8. All the pre and post compression parameters were found to be within the acceptable limits. The formulations were optimized based on results of dissolution and formulations CF5 for immediate release & VF11 for sustained release. VF11 was formulated with addition of superdisentigrant and showed better controlled release and dissolution similar to VF8. The release kinetics of Valsartan was subject to curve fitting analysis in order to identify the best fit kinetic model. The regression analysis proves that VF11 follow first order release and drug release by diffusion process based on Fick’s law of diffusion. The data for stability studies infer no considerable change in drug content, dissolution rates and other quality control test were within limits.
Keywords: Bilayer tablets, clopidogrel, valsartan, direct compression method. |
doi_str_mv | 10.22270/jddt.v13i12.6067 |
format | Article |
fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_22270_jddt_v13i12_6067</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_22270_jddt_v13i12_6067</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_22270_jddt_v13i12_60673</originalsourceid><addsrcrecordid>eNqdkMFOwzAMhiMEEhPsAbj5BVaSdKx3yhBInNjENfIaZ2RKmilJQXsnHpJ2oNEzvtiyP_-2fsZuBC-klBW_3Wmdiw9RWiGLBV9UZ2wi5R2fCVFV56P6kk1T2vE-qjkveTlhX0tjqMkQDNQxpCZET86FRLAK2nYebAurLmW0LWl4JUfYz17wQHHYeUOXMGZsB-7eumN_jRtHGT5tfofahb3VYRvJASZ49p60xUzwELvtSQ9bPZLqub-TY-6aXZieoulvvmLicbmun2ZN_3qKZNQ-Wo_xoARXR2fU4Iz6cUYNzpT_2fkGG4VxRA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Effect of Croscormellose Sodium in Sustained Release Layer of Valsartan in Bilayer Tablet with Clopidogrel as Immediate Drug Release and Valsartan as Sustained Drug Release</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Fatima, Hajra ; Mohammed, Shahid ; Begum, Arshiya</creator><creatorcontrib>Fatima, Hajra ; Mohammed, Shahid ; Begum, Arshiya</creatorcontrib><description>The aim of the study was to design and evaluate bilayer tablets of clopidogrel as immediate release and quick relief and valsartan for sustained release and check the effect of croscarmellose sodium (2%) in Carbopol for sustained release action. Bilayer tablets was prepared using direct compression method. Super disintegrants such as Crospovidone, Croscarmellose sodium were evaluated for immediate release of clopidogrel. Polymers HPMC K4, guar gum, ethyl cellulose and carbopol for controlling release of Valsartan. The compressed bilayer tablets were evaluated for weight variation, thickness, hardness, friability, drug content and in vitro drug release in 0.1N HCl and phosphate buffer pH 6.8. All the pre and post compression parameters were found to be within the acceptable limits. The formulations were optimized based on results of dissolution and formulations CF5 for immediate release & VF11 for sustained release. VF11 was formulated with addition of superdisentigrant and showed better controlled release and dissolution similar to VF8. The release kinetics of Valsartan was subject to curve fitting analysis in order to identify the best fit kinetic model. The regression analysis proves that VF11 follow first order release and drug release by diffusion process based on Fick’s law of diffusion. The data for stability studies infer no considerable change in drug content, dissolution rates and other quality control test were within limits.
Keywords: Bilayer tablets, clopidogrel, valsartan, direct compression method.</description><identifier>ISSN: 2250-1177</identifier><identifier>EISSN: 2250-1177</identifier><identifier>DOI: 10.22270/jddt.v13i12.6067</identifier><language>eng</language><ispartof>Journal of drug delivery and therapeutics, 2023-12, Vol.13 (12), p.35-50</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0009-0005-5748-3845 ; 0009-0003-7586-5981 ; 0009-0007-3314-5600</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Fatima, Hajra</creatorcontrib><creatorcontrib>Mohammed, Shahid</creatorcontrib><creatorcontrib>Begum, Arshiya</creatorcontrib><title>Effect of Croscormellose Sodium in Sustained Release Layer of Valsartan in Bilayer Tablet with Clopidogrel as Immediate Drug Release and Valsartan as Sustained Drug Release</title><title>Journal of drug delivery and therapeutics</title><description>The aim of the study was to design and evaluate bilayer tablets of clopidogrel as immediate release and quick relief and valsartan for sustained release and check the effect of croscarmellose sodium (2%) in Carbopol for sustained release action. Bilayer tablets was prepared using direct compression method. Super disintegrants such as Crospovidone, Croscarmellose sodium were evaluated for immediate release of clopidogrel. Polymers HPMC K4, guar gum, ethyl cellulose and carbopol for controlling release of Valsartan. The compressed bilayer tablets were evaluated for weight variation, thickness, hardness, friability, drug content and in vitro drug release in 0.1N HCl and phosphate buffer pH 6.8. All the pre and post compression parameters were found to be within the acceptable limits. The formulations were optimized based on results of dissolution and formulations CF5 for immediate release & VF11 for sustained release. VF11 was formulated with addition of superdisentigrant and showed better controlled release and dissolution similar to VF8. The release kinetics of Valsartan was subject to curve fitting analysis in order to identify the best fit kinetic model. The regression analysis proves that VF11 follow first order release and drug release by diffusion process based on Fick’s law of diffusion. The data for stability studies infer no considerable change in drug content, dissolution rates and other quality control test were within limits.
Keywords: Bilayer tablets, clopidogrel, valsartan, direct compression method.</description><issn>2250-1177</issn><issn>2250-1177</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqdkMFOwzAMhiMEEhPsAbj5BVaSdKx3yhBInNjENfIaZ2RKmilJQXsnHpJ2oNEzvtiyP_-2fsZuBC-klBW_3Wmdiw9RWiGLBV9UZ2wi5R2fCVFV56P6kk1T2vE-qjkveTlhX0tjqMkQDNQxpCZET86FRLAK2nYebAurLmW0LWl4JUfYz17wQHHYeUOXMGZsB-7eumN_jRtHGT5tfofahb3VYRvJASZ49p60xUzwELvtSQ9bPZLqub-TY-6aXZieoulvvmLicbmun2ZN_3qKZNQ-Wo_xoARXR2fU4Iz6cUYNzpT_2fkGG4VxRA</recordid><startdate>20231215</startdate><enddate>20231215</enddate><creator>Fatima, Hajra</creator><creator>Mohammed, Shahid</creator><creator>Begum, Arshiya</creator><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0009-0005-5748-3845</orcidid><orcidid>https://orcid.org/0009-0003-7586-5981</orcidid><orcidid>https://orcid.org/0009-0007-3314-5600</orcidid></search><sort><creationdate>20231215</creationdate><title>Effect of Croscormellose Sodium in Sustained Release Layer of Valsartan in Bilayer Tablet with Clopidogrel as Immediate Drug Release and Valsartan as Sustained Drug Release</title><author>Fatima, Hajra ; Mohammed, Shahid ; Begum, Arshiya</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_22270_jddt_v13i12_60673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fatima, Hajra</creatorcontrib><creatorcontrib>Mohammed, Shahid</creatorcontrib><creatorcontrib>Begum, Arshiya</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of drug delivery and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fatima, Hajra</au><au>Mohammed, Shahid</au><au>Begum, Arshiya</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of Croscormellose Sodium in Sustained Release Layer of Valsartan in Bilayer Tablet with Clopidogrel as Immediate Drug Release and Valsartan as Sustained Drug Release</atitle><jtitle>Journal of drug delivery and therapeutics</jtitle><date>2023-12-15</date><risdate>2023</risdate><volume>13</volume><issue>12</issue><spage>35</spage><epage>50</epage><pages>35-50</pages><issn>2250-1177</issn><eissn>2250-1177</eissn><abstract>The aim of the study was to design and evaluate bilayer tablets of clopidogrel as immediate release and quick relief and valsartan for sustained release and check the effect of croscarmellose sodium (2%) in Carbopol for sustained release action. Bilayer tablets was prepared using direct compression method. Super disintegrants such as Crospovidone, Croscarmellose sodium were evaluated for immediate release of clopidogrel. Polymers HPMC K4, guar gum, ethyl cellulose and carbopol for controlling release of Valsartan. The compressed bilayer tablets were evaluated for weight variation, thickness, hardness, friability, drug content and in vitro drug release in 0.1N HCl and phosphate buffer pH 6.8. All the pre and post compression parameters were found to be within the acceptable limits. The formulations were optimized based on results of dissolution and formulations CF5 for immediate release & VF11 for sustained release. VF11 was formulated with addition of superdisentigrant and showed better controlled release and dissolution similar to VF8. The release kinetics of Valsartan was subject to curve fitting analysis in order to identify the best fit kinetic model. The regression analysis proves that VF11 follow first order release and drug release by diffusion process based on Fick’s law of diffusion. The data for stability studies infer no considerable change in drug content, dissolution rates and other quality control test were within limits.
Keywords: Bilayer tablets, clopidogrel, valsartan, direct compression method.</abstract><doi>10.22270/jddt.v13i12.6067</doi><orcidid>https://orcid.org/0009-0005-5748-3845</orcidid><orcidid>https://orcid.org/0009-0003-7586-5981</orcidid><orcidid>https://orcid.org/0009-0007-3314-5600</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2250-1177 |
ispartof | Journal of drug delivery and therapeutics, 2023-12, Vol.13 (12), p.35-50 |
issn | 2250-1177 2250-1177 |
language | eng |
recordid | cdi_crossref_primary_10_22270_jddt_v13i12_6067 |
source | EZB-FREE-00999 freely available EZB journals |
title | Effect of Croscormellose Sodium in Sustained Release Layer of Valsartan in Bilayer Tablet with Clopidogrel as Immediate Drug Release and Valsartan as Sustained Drug Release |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T22%3A26%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20Croscormellose%20Sodium%20in%20Sustained%20Release%20Layer%20of%20Valsartan%20in%20Bilayer%20Tablet%20with%20Clopidogrel%20as%20Immediate%20Drug%20Release%20and%20Valsartan%20as%20Sustained%20Drug%20Release&rft.jtitle=Journal%20of%20drug%20delivery%20and%20therapeutics&rft.au=Fatima,%20Hajra&rft.date=2023-12-15&rft.volume=13&rft.issue=12&rft.spage=35&rft.epage=50&rft.pages=35-50&rft.issn=2250-1177&rft.eissn=2250-1177&rft_id=info:doi/10.22270/jddt.v13i12.6067&rft_dat=%3Ccrossref%3E10_22270_jddt_v13i12_6067%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |